In memoriam: Joel Dain
Joel A. Dain, a longtime professor at the University of Rhode Island and a member of the American Society for Biochemistry and Molecular Biology since 1970, died Aug. 21 in Kingston, Rhode Island. He was 89.

Born Oct. 26, 1931, in the Bronx, New York, Dain earned a bachelor’s degree in chemistry from the University of Illinois Urbana–Champaign and a Ph.D. in biochemistry from Cornell University. He was a professor of biochemistry at URI for almost 60 years. Dain and his family traveled for his work, living in Germany, California and Japan while he collaborated with scientists at local universities. He gave invited lectures at conferences and universities around the world. He retired in 2015 and worked as an emeritus professor until his death.
Dain’s lab studied complex glycated protein structures called advanced glycation endproducts, or AGEs, that are associated with complications in diabetes and other diseases. They researched the formation of AGEs with dietary sugars such as fructose, galactose, ribose and glyceraldhyde. Of particular interest was glucosamine, an analog of glucose in which an amine replaces the hydroxyl group on carbon-2. It is widely used as a dietary supplement to relieve osteoarthritis symptoms. The lab worked to develop capillary electrophoresis and high-performance liquid chromatography methods to describe the formation of previously undescribed AGEs.
From early on, Dain opened his lab to graduate students of all genders from all over the world and from diverse backgrounds. He mentored numerous grad students and postdocs with whom he maintained regular contact. In addition to the ASBMB, he belonged to the American Chemical Society and the American Association of University Professors.
Dain was a runner in high school and a basketball player from his teens into his 80s. He also loved tennis and was an avid reader of suspense and detective novels. A lifelong stamp collector, he taught for many years stamp collecting to children through a local community center.
Dain is survived by his wife of 64 years, Eleanor; three sons, Peter, Jonathan and Leonard, and their wives; and six grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.